poisar

Stocks · News reference

Vaxcyte Announces First Patient Enrollment In Phase 1 Study Evaluating Group A Streptococcus Vaccine VAX-A1

BenzingaJun 2, 2026, 8:09 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jun 2, 2026, 8:09 PM
Checked
Jun 2, 2026, 8:09 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARJul 15, 2026, 8:05 PMSEC EDGAR

    8-K filing — Vaxcyte, Inc. (PCVX)

    Filed: 2026-07-15 AccNo: 0001649094-26-000030 Size: 144 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

    Read original at edgar